ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209 | +22.2% | 9 | -75.0% | 0.00% | – |
| Q2 2023 | $171 | -12.8% | 36 | +44.0% | 0.00% | -100.0% |
| Q1 2023 | $196 | +7.7% | 25 | -39.0% | 0.01% | +500.0% |
| Q4 2022 | $182 | -99.9% | 41 | -86.2% | 0.00% | -88.9% |
| Q3 2022 | $256,000 | -5.9% | 297 | -29.3% | 0.01% | +12.5% |
| Q2 2022 | $272,000 | -23.6% | 420 | -23.9% | 0.01% | -20.0% |
| Q1 2022 | $356,000 | -31.4% | 552 | -35.7% | 0.01% | -16.7% |
| Q4 2021 | $519,000 | +737.1% | 858 | +10625.0% | 0.01% | -58.6% |
| Q3 2021 | $62,000 | +313.3% | 8 | -98.5% | 0.03% | +123.1% |
| Q3 2019 | $15,000 | – | 527 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |